| |
| |
|
| Insider
Information: |
Edelman Joseph |
| Relationship: |
Former 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
42 |
|
| Direct
Shares |
630,171 |
|
|
Indirect Shares
|
332,164,708 |
|
|
| Direct
Value |
$1,466,262 |
|
|
|
Indirect Value
|
$2,852,575,947 |
|
|
| Total
Shares |
332,794,879 |
|
|
| Total
Value |
$2,854,042,209 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
79
|
21
|
|
Stock
price went up :
|
50
|
11
|
| Stock
price went down : |
29
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
1.7
|
1.1
|
| Percentage
Gain/Loss : |
 13.4%
|
197.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2008-06-23 |
0 |
2008-06-23 |
6,387,546 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
10% Owner |
|
0 |
2011-11-02 |
0 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
10% Owner |
2012-11-01 |
133,133 |
2012-11-29 |
2,595,293 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
|
0 |
2017-06-19 |
4,533,728 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
|
0 |
2018-10-03 |
20,724,424 |
Premium* |
|
|
VBI Vaccines Inc |
VBIV |
10% Owner |
|
0 |
2014-07-25 |
2,610,356 |
Premium* |
|
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
|
0 |
2024-04-05 |
9,275,851 |
Premium* |
|
|
Aravive Inc |
ARAV |
10% Owner |
|
0 |
2017-09-22 |
2,099,563 |
Premium* |
|
|
Kadmon Holdings, Llc |
KDMN |
10% Owner |
|
0 |
2019-11-18 |
14,636,334 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2017-09-29 |
0 |
2018-08-10 |
4,070,357 |
Premium* |
|
|
Global Blood Therapeutics, Inc. |
GBT |
10% Owner |
2017-12-19 |
0 |
2017-12-19 |
4,889,066 |
Premium* |
|
|
Corium International, Inc. |
CORI |
10% Owner |
2018-01-16 |
0 |
2018-10-12 |
2,724,686 |
Premium* |
|
|
Albireo Pharma Inc |
ALBO |
10% Owner |
2018-01-25 |
0 |
2022-10-13 |
1,939,723 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
2018-01-30 |
0 |
2024-01-11 |
6,906,646 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
10% Owner |
2018-02-13 |
0 |
2019-01-08 |
2,253,376 |
Premium* |
|
|
Motus Gi Holdings Inc |
MOTS |
10% Owner |
2018-02-16 |
0 |
2021-01-22 |
2,660,542 |
Premium* |
|
|
Quotient Ltd |
QTNTQ |
10% Owner |
2018-05-22 |
0 |
2022-10-31 |
7,945,211 |
Premium* |
|
|
Dova Pharmaceuticals, Inc. |
DOVA |
10% Owner |
2018-06-04 |
0 |
2019-11-12 |
0 |
Premium* |
|
|
Meiragtx Holdings Plc |
MGTX |
10% Owner |
2018-06-08 |
0 |
2023-05-05 |
11,281,103 |
Premium* |
|
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
10% Owner |
2018-07-20 |
0 |
2022-04-18 |
5,321,032 |
Premium* |
|
|
Agile Therapeutics Inc |
AGRX |
10% Owner |
2018-07-26 |
0 |
2021-10-13 |
21,654,485 |
Premium* |
|
|
Verrica Pharmaceuticals Inc. |
VRCA |
10% Owner |
2018-06-19 |
0 |
2023-12-29 |
7,099,182 |
Premium* |
|
|
Athenex, Inc. |
ATNX |
10% Owner |
2019-05-06 |
0 |
2020-09-14 |
13,532,467 |
Premium* |
|
|
ADMA Biologics Inc |
ADMA |
10% Owner |
2019-05-21 |
0 |
2021-09-30 |
13,262,375 |
Premium* |
|
|
Foamix Pharmaceuticals Ltd |
FOMX |
10% Owner |
|
0 |
2019-07-29 |
11,203,881 |
Premium* |
|
|
Lyra Therapeutics, Inc. |
LYRA |
Director, 10% Owner |
2020-05-05 |
0 |
2023-05-31 |
12,757,563 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
10% Owner |
2020-06-09 |
0 |
2021-08-16 |
4,935,057 |
Premium* |
|
|
Leap Therapeutics, Inc. |
LPTX |
10% Owner |
2020-06-22 |
0 |
2020-06-22 |
8,476,496 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
Director, 10% Owner |
|
0 |
2023-12-29 |
5,402,964 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2020-10-20 |
0 |
2024-02-20 |
10,794,876 |
Premium* |
|
|
Scynexis Inc |
SCYX |
10% Owner |
2021-01-20 |
0 |
2021-01-22 |
1,800,000 |
Premium* |
|
|
Landos Biopharma, Inc. |
LABP |
Director, 10% Owner |
|
0 |
2021-02-09 |
17,960,839 |
Premium* |
|
|
Astria Therapeutics, Inc |
ATXS |
Director |
|
0 |
2024-02-01 |
6,485,420 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
3,314,032 |
Premium* |
|
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2021-04-27 |
0 |
2021-10-12 |
2,487,019 |
Premium* |
|
|
Nautilus Biotechnology, Inc |
NAUT |
10% Owner |
2021-05-24 |
497,038 |
2021-12-08 |
9,111,151 |
Premium* |
|
|
Isoplexis Corp |
ISO |
10% Owner |
2021-10-12 |
0 |
2021-10-12 |
3,554,587 |
Premium* |
|
|
Lianbio |
LIAN |
Director, 10% Owner |
|
0 |
2024-02-15 |
57,575,533 |
Premium* |
|
|
Acrivon Therapeutics, Inc. |
ACRV |
10% Owner |
|
0 |
2024-04-11 |
5,360,858 |
Premium* |
|
|
Chembio Diagnostics Inc |
CEMI |
Former 10% Owner |
2023-04-04 |
0 |
2023-04-27 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
10% Owner |
|
0 |
2023-06-06 |
2,207,753 |
Premium* |
|
|
Cargo Therapeutics, Inc. |
CRGX |
Former 10% Owner |
2023-11-14 |
0 |
2023-11-14 |
333,333 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
304 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRCA |
Verrica Pharmaceuticals I... |
10% Owner |
– – • |
2018-06-19 |
4 |
B |
$15.00 |
$15,000,000 |
I/I |
1,000,000 |
3,410,412 |
1.5 |
- |
|
| SLDB |
Solid Biosciences Inc |
10% Owner |
– – • |
2020-12-10 |
4 |
A |
$3.70 |
$15,000,000 |
I/I |
4,054,054 |
10,803,857 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
– – • |
2021-05-03 |
4 |
B |
$12.50 |
$15,000,000 |
I/I |
1,200,000 |
9,903,879 |
1.5 |
% |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • • |
2022-12-02 |
4 |
A |
$0.00 |
$15,249,996 |
I/I |
2,601,763 |
73,107 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
10% Owner |
– – • |
2020-02-11 |
4 |
B |
$3.50 |
$15,972,950 |
I/I |
4,563,700 |
16,084,802 |
1.5 |
% |
|
| ADMA |
ADMA Biologics Inc |
10% Owner |
– – • |
2019-05-21 |
4 |
B |
$4.00 |
$16,000,000 |
I/I |
4,000,000 |
11,521,102 |
1.5 |
- |
|
| ALBO |
Albireo Pharma Inc |
10% Owner |
– – • |
2020-09-14 |
4 |
B |
$40.00 |
$16,000,000 |
I/I |
400,000 |
2,360,139 |
1.5 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
10% Owner |
– – • |
2021-03-16 |
4 |
B |
$19.00 |
$16,150,000 |
I/I |
850,000 |
3,314,032 |
1.5 |
% |
|
| SLDB |
Solid Biosciences Inc |
10% Owner |
– – • |
2018-01-30 |
4 |
B |
$16.00 |
$16,546,520 |
I/I |
1,020,000 |
3,927,222 |
1.5 |
- |
|
| QTNTQ |
Quotient Ltd |
10% Owner |
– – • |
2019-11-07 |
4 |
B |
$7.00 |
$17,500,000 |
I/I |
2,500,000 |
13,289,054 |
1.5 |
- |
|
| MGTX |
Meiragtx Holdings Plc |
10% Owner |
– – • |
2019-03-01 |
4 |
B |
$13.80 |
$18,000,002 |
I/I |
1,304,348 |
6,007,746 |
1.5 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Director |
– • • |
2020-09-22 |
4 |
B |
$17.00 |
$18,000,008 |
I/I |
1,058,824 |
3,114,805 |
2.25 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2017-07-13 |
4 |
B |
$12.25 |
$18,375,000 |
I/I |
1,500,000 |
17,888,597 |
1.5 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • • |
2024-01-11 |
4 |
B |
$5.53 |
$18,861,243 |
I/I |
3,410,713 |
6,833,539 |
2.25 |
% |
|
| ATNX |
Athenex, Inc. |
10% Owner |
– – • |
2020-09-14 |
4 |
B |
$11.00 |
$19,800,000 |
I/I |
1,800,000 |
13,532,467 |
1.5 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2023-10-16 |
4 |
B |
$22.81 |
$19,999,990 |
I/I |
876,808 |
10,794,876 |
2.1 |
% |
|
| MGTX |
Meiragtx Holdings Plc |
10% Owner |
– – • |
2018-06-12 |
4 |
B |
$15.00 |
$19,999,995 |
I/I |
1,333,333 |
4,703,398 |
1.5 |
- |
|
| LABP |
Landos Biopharma, Inc. |
Director |
– • • |
2021-02-08 |
4 |
B |
$16.00 |
$20,000,000 |
I/I |
1,250,000 |
7,049,564 |
2.25 |
- |
|
| ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
– – • |
2024-04-11 |
4 |
B |
$8.50 |
$20,000,500 |
I/I |
2,353,000 |
5,360,858 |
1.5 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
10% Owner |
– – • |
2018-03-15 |
4 |
B |
$29.50 |
$20,650,000 |
I/I |
700,000 |
4,313,611 |
1.5 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2021-10-25 |
4 |
B |
$19.80 |
$23,760,000 |
I/I |
1,200,000 |
5,163,517 |
1.5 |
% |
|
| LYRA |
Lyra Therapeutics, Inc. |
Director |
– • • |
2022-04-12 |
4 |
B |
$4.22 |
$24,999,997 |
I/I |
5,924,170 |
7,858,285 |
2.25 |
- |
|
| MGTX |
Meiragtx Holdings Plc |
10% Owner |
– – • |
2023-05-05 |
4 |
B |
$5.75 |
$25,000,000 |
I/I |
4,347,826 |
11,281,103 |
1.5 |
% |
|
| ATXS |
Astria Therapeutics, Inc |
Director |
– • – |
2024-02-01 |
4 |
B |
$12.09 |
$29,999,522 |
I/I |
2,481,350 |
4,873,721 |
2.1 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2020-10-27 |
4 |
B |
$10.00 |
$30,000,000 |
I/I |
3,000,000 |
3,157,295 |
2.1 |
% |
|
304 Records found
|
|
Page 12 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
